The United States risks losing its leadership role in biomedical research due to recent policy changes by the National Institutes of Health (NIH), which propose significant reductions in funding for essential infrastructure that supports research. The longstanding relationship between universities and the federal government has relied heavily on federal grants, which are crucial for covering both direct and indirect research costs. With an estimated $9 billion allocated to indirect costs in 2023, cuts could hinder critical lab facilities and equipment, ultimately affecting innovation and discovery in the field.
"NIH grants have supported the direct costs of my own scientific research on developing treatments for conditions ranging from cancer to eye diseases."
Collection
[
|
...
]